Concepedia

Publication | Open Access

Comparisons between tumor burden and other prognostic factors that influence survival of patients with non‐small cell lung cancer treated with immune checkpoint inhibitors

27

Citations

26

References

2019

Year

Abstract

TB is a useful, clinically measurable prognostic factor of survival in NSCLC patients treated with ICIs.

References

YearCitations

Page 1